Milena Cannella

Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous Malformations

Christina L. Liquori, Michel J. Berg, Adrian M. Siegel et al. · The American Journal of Human Genetics · 2003 · 343 citations · Full text

Medicine, Molecular Genetics, Neuroscience +14

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Andrea Ciarmiello, Milena Cannella, Secondo Lastoria et al. · PubMed · 2006 · 299 citations

Life Sciences, Neurology, Neuroscience +17

Impaired PGC-1α function in muscle in Huntington's disease

Rajnish Kumar Chaturvedi, Peter J. Adhihetty, Shubha Shukla et al. · Human Molecular Genetics · 2009 · 235 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients

Andrea Ciammola, Jenny Sassone, Milena Cannella et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2007 · 170 citations

Life Sciences, Neurology, Neuroscience +14

Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer’s Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective

Filippo Caraci, Gemma Molinaro, Giuseppe Battaglia et al. · Molecular Pharmacology · 2010 · 117 citations

Medicine, Neuroscience, Pharmacology +17